Chronic obstructive pulmonary disease AstraZeneca AERISTO trial

Chronic obstructive pulmonary disease AstraZeneca AERISTO trial

AstraZeneca reports negative top-line results from AERISTO trial

AstraZeneca has reported negative top-line results from the AERISTO trial, a Phase IIIb study of Bevespi Aerosphere (glycopyrronium/formoterol fumarate) against…

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive.

Clinical Trials Arena Pipeline Moves

Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday.

Clinical Trials Arena Weekly Roundup

Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday.

Pharma Technology Focus Magazine

The pharmaceutical industry's most comprehensive news and information delivered every month.

I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy

SUBSCRIBED

Thank you for subscribing to Clinical Trials Arena

Clinical Trials Arena Pipeline Moves

Clinical Trials Arena Weekly Roundup

Pharma Technology Focus Magazine

THANK YOU